<?xml version="1.0" encoding="UTF-8"?>
<p>During the SARS epidemic, in a cohort of 39 nondiabetic nonglucocorticoid-treated patients, 20 developed new-onset fasting hyperglycemia (&gt;7 mmol/L), starting from the third day in the hospital and reversing by 2 weeks in the majority, whereas 2 patients continued to have diabetes 3 years later [
 <xref rid="CIT0092" ref-type="bibr">92</xref>]. This was not observed in the control groups with non-SARS pneumonia, and healthy siblings of SARS patients. Postprandial plasma glucose, insulin levels, and insulin resistance were not reported.
</p>
